Fortrea (FTRE) Stock: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$17.20
0.18 (1.06%)
▲
5d:
-7.63%
30d:
-6.16%
90d:
+1.96%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: FTRE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: FTRE shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$34.14
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.20
18.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $17.20, which is considered oversold relative to its 30-day fair value range of $17.61 to $18.83. The stock's valuation (Forward PE: 15.1) is in line with its historical norms (15.4). Remarkably, the market is currently pricing in an annual earnings decline of 0.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $16.07, while resistance sits at $19.14.
Market Sentiment: FTRE scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.55 (+19.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $16.07, while resistance sits at $19.14.
Market Sentiment: FTRE scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.55 (+19.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$17.61 -
$18.83
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($20.55)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$17.61 -
$18.83
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$16.07
Resistance Level
$19.14
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.11
Wall Street Target
$20.55
(+19.5%)
Revenue Growth (YoY)
-4.5%
Earnings Growth (YoY)
-57.4%
Profit Margin
-3.2%
Valuation Discount vs History
-0.6% cheaper
PE vs Historical
15.1 vs 15.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.6%
(market-implied from PE analysis)
1-Year Target
$17.10
(-1%)
2-Year Target
$16.99
(-1%)
3-Year Target
$16.89
(-2%)
3-Yr Target (if PE normalizes)
(PE: 15→15)
$17.22
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 35.5%)
$57.09
(+232%)
Base:
(SPY PE: 15.1, Growth: 35.5%)
$42.76
(+149%)
Bear:
(PE: 12.8, Growth: 35.5%)
$36.35
(+111%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.1 to 15.4
Stabilization Target:
$17.53
(+1.9%)
PE Expansion Potential:
+1.9%
Share & Embed Analysis
Last updated: September 13, 2026 8:23 AM ET
Data refreshes hourly during market hours. Next update: 9:23 AM
Data refreshes hourly during market hours. Next update: 9:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 44 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$135 | 47 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
